ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,790, issued on April 15, was assigned to SinoCellTech Ltd. (Beijing).
"Humanized anti-PD-1 antibody and the use thereof" was invented by Liangzhi Xie (Beijing), Chunyun Sun (Beijing) and Juan Ma (Beijing).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a recombinant humanized monoclonal antibody against programmed cell death receptor-1 (PD-1) or an antigen-binding fragment thereof, which can be used in tumor or cancer immunotherapy. The disclosure also provides nucleic acid sequences encoding said antibody or antigen-binding fragment thereof, vectors containing said nucleic acid sequences, pharmaceutical compositions and...